All News

Medical Xpress / Investigators study ivermectin's 'ability to kill cancer cells'

The National Cancer Institute, the federal research agency charged with leading the war against the nation's second-largest killer, is studying ivermectin as a potential cancer treatment, according to its top official.

Feb 11, 2026 in Oncology & Cancer
Phys.org / 5,300-year-old 'bow drill' rewrites story of ancient Egyptian tools

A new study reveals that Egyptians were using a mechanically sophisticated drilling tool far earlier than previously suggested. Researchers at Newcastle University, and the Academy of Fine Arts, Vienna, have re-examined a ...

Feb 9, 2026 in Other Sciences
Phys.org / Rapid response launched to tackle new yellow rust strains threatening UK wheat

The UK's wheat is under threat from a newly identified strain of the yellow rust pathogen, prompting an urgent mobilization of research institutes to protect harvests. The new strain, identified in 2025, has overcome a key ...

Feb 11, 2026 in Biology
Tech Xplore / Ultrafast nanolasers mimic how the brain imagines unseen parts of the world

A new study has demonstrated how networks of spiking nanolasers could emulate a key principle of brain function: to imagine things that we cannot directly perceive by sampling from internal models of the world. The study, ...

Feb 10, 2026 in Hardware
Medical Xpress / Discovery of unique brain tumor subtypes offers hope for targeted glioma therapies

Researchers have uncovered the mechanisms behind three unique subtypes of mismatch repair deficient high-grade gliomas. The findings provide a clearer understanding of how these tumors develop, explain why patients respond ...

Feb 10, 2026 in Oncology & Cancer
Phys.org / Novel nanosheets boost clot clearing while limiting systemic bleeding

Thrombotic disorders—such as ischemic stroke, heart attack, pulmonary embolism, and deep vein thrombosis—are principal contributors to global mortality. However, conventional thrombolytic therapies are often constrained ...

Feb 10, 2026 in Nanotechnology
Phys.org / Versatile enzyme that quickly, accurately synthesizes RNA can also perform reverse transcription

From vaccines and diagnostics to emerging gene-based therapies, RNA molecules are now central to modern medicine. But as their use continues to grow, so does a fundamental challenge: producing RNA quickly, accurately and ...

Feb 10, 2026 in Biology
Phys.org / New study uses Neanderthals to demonstrate gap between generative AI and scholarly knowledge

Technological advances over the past four decades have turned mobile devices and computers into the world's largest library, where information is just a tap away. Phones, laptops, tablets, smartwatches—they're a part of ...

Feb 6, 2026 in Other Sciences
Phys.org / Paper vs. screen for kids: Why typing skill, not motivation, drove better digital writing

A nationwide study of more than 500 Australian primary school students in Year 2 has revealed how beginner writers' attitude and motivation toward writing is related to the quality of their writing and writing skills (handwriting ...

Feb 11, 2026 in Other Sciences
Phys.org / Passing got faster and more accurate in top soccer leagues, study finds

The amount and accuracy of passing in the game of soccer—called football across much of the world—has climbed in recent years, according to new research. The average passing volume, pass accuracy, and the percentage of ...

Feb 10, 2026 in Other Sciences
Medical Xpress / Genetic link between type 2 diabetes and high blood pressure uncovered

Type 2 diabetes and high blood pressure share a genetic link, according to new research from the University of Surrey, U.K., and the Université de Lille, France. In a large-scale study, scientists examined genetic data linked ...

Feb 10, 2026 in Cardiology
Medical Xpress / Ovarian cancer cells surprise scientists—the body's own defense may be the key to longer survival

A new study sheds light on why some patients with the most aggressive form of ovarian cancer respond better to treatment than others. Tumors positive for a molecule called MHC class II are linked to stronger immune responses ...

Feb 10, 2026 in Oncology & Cancer